ロード中...
Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
BACKGROUND: Vonoprazan is a novel potassium‐competitive acid blocker which may provide clinical benefit in acid‐related disorders. AIM: To verify the non‐inferiority of vonoprazan vs. lansoprazole in patients with erosive oesophagitis (EE), and to establish its long‐term safety and efficacy as maint...
保存先:
| 出版年: | Aliment Pharmacol Ther |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4738414/ https://ncbi.nlm.nih.gov/pubmed/26559637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.13461 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|